北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 期刊论文
学科主题: 临床医学
题名:
Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)
作者: Hu, C. S.1; Chan, A.2; Gao, L.3; Ahn, M. -J.4; Cohen, E.5; Ang, M. -K.6; Cheng, Y.7; Hu, Q.8; Kim, S. -B.9; Li, P.10; Sun, Y.11; Fan, B.12; Cheng, G.13; Ehrnrooth, E.14; Wang, C. -H.15
刊名: ANNALS OF ONCOLOGY
发表日期: 2015-12-01
卷: suppl.9, 页:100-100
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
语种: 英语
WOS记录号: WOS:000367158700338
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/65199
Appears in Collections:北京大学临床肿瘤学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
2.Tumor Hosp Jilin Prov, Div Thorac Oncol, Changchun, Peoples R China
3.Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
4.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
5.Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China
6.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
7.Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
8.Univ Calif San Diego, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA
9.Zhejiang Canc Hosp, Head & Neck Canc Ctr, Hangzhou, Zhejiang, Peoples R China
10.Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
11.Peking Univ, Canc Hosp, Sch Oncol, Beijing 100871, Peoples R China
12.Boehringer Ingelheim China Investment Co Ltd, Med, Shanghai, Peoples R China
13.Boehringer Ingelheim China Investment Co Ltd, Biometr & Data Management, Shanghai, Peoples R China
14.Boehringer Ingelheim GmbH & Co KG, TA Oncol, Copenhagen, Denmark
15.Chang Gung Mem Hosp Keelung, Dept Canc Ctr, Taipei, Taiwan

Recommended Citation:
Hu, C. S.,Chan, A.,Gao, L.,et al. Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)[J]. ANNALS OF ONCOLOGY,2015,suppl.9:100-100.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Hu, C. S.]'s Articles
[Chan, A.]'s Articles
[Gao, L.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Hu, C. S.]‘s Articles
[Chan, A.]‘s Articles
[Gao, L.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace